Apogenix’s APG101 demonstrates efficacy in preclinical MDS study
24 March 2016 | By Victoria White
Apogenix’s APG101 rescues the production of red blood cells (erythropoiesis) in bone marrow samples from patients with lower-risk myelodysplastic syndromes...